Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus.

cholesteryl ester transfer protein (CETP) diabetes dyslipidemia high-density lipoprotein (HDL) lipid nanoparticles peripheral artery disease (PAD) unesterified cholesterol

Journal

Vascular medicine (London, England)
ISSN: 1477-0377
Titre abrégé: Vasc Med
Pays: England
ID NLM: 9610930

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 18 6 2021
medline: 11 3 2022
entrez: 17 6 2021
Statut: ppublish

Résumé

Low high-density lipoprotein (HDL)-cholesterol is frequent in patients with peripheral artery disease (PAD) and also in type 2 diabetes mellitus (T2DM), the major risk factor for PAD. The transfer of cholesterol from the other lipoproteins to HDL is an important aspect of HDL metabolism and function, and may contribute to atherogenic mechanisms that lead to PAD development. The aim of this study was to investigate the status of cholesterol transfers in patients with PAD without or with T2DM. Patients with PAD ( Low-density lipoprotein (LDL)-cholesterol and triglycerides were similar in the three groups. Compared to controls, HDL-C was lower in PAD + DM ( Deficient cholesterol transfer to HDL may play a role in PAD pathogenesis. Since UC transfer to HDL was lower in PAD + DM compared to PAD alone, it is possible that defective HDL metabolism may contribute to the higher PAD incidence in patients with T2DM.Keywords.

Identifiants

pubmed: 34137646
doi: 10.1177/1358863X211021142
doi:

Substances chimiques

Cholesterol, HDL 0
Lipoproteins, HDL 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

602-607

Auteurs

Flávio Roberto Cavalleiro de Macedo Ribeiro (FRC)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Carolina Heitmann Mares Azevedo Ribeiro (CHMA)

Departamento de Ciencias Farmaceuticas, Instituto de Ciencias da Saude, Universidade Federal do Pará, Belém, Pará, Brazil.

Thauany Martins Tavoni (TM)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Faculdade de Ciencias Farmaceuticas, Universidade de Sao Paulo, Sao Paulo, Brazil.

Erica Dos Santos Sarges (E)

Departamento de Ciencias Farmaceuticas, Instituto de Ciencias da Saude, Universidade Federal do Pará, Belém, Pará, Brazil.

Fatima Rodrigues Freitas (FR)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Noedir Antonio Groppo Stolf (NAG)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Roberto Kalil Filho (R)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.

Raul Cavalcante Maranhão (RC)

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Faculdade de Ciencias Farmaceuticas, Universidade de Sao Paulo, Sao Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH